Jesse Elias
Biographic Data
| ID | 6738552 |
|---|---|
| NAME | Jesse Elias |
| GIVEN NAMES | Jesse |
| FAMILY NAME | Elias |
| SIGNATURE | ELIAS J |
| AFFILIATIONS | University of California, San Francisco |
| ORCID | 0000-0002-3250-3329 |
| VERIFIED | Yes |
| TOTAL WORKS | 5 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 5 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2018 |
| LATEST PUBLICATION YEAR | 2019 |
| H-INDEX | 0 |
Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review
Background. Tobacco companies have actively promoted the substitution of cigarettes with purportedly safer tobacco products (e.g., smokeless tobacco, e-cigarettes) as tobacco harm reduction (THR). Given the tobacco, e-cigarette, and pharmaceutical industries’ substantial financial interests, we quantified industry influence on support for THR. Objectives. To analyze a comprehensive set of articles published in peer-reviewed journals assessing fun…
Docile, criminal, and upwardly mobile: Visual news framing of Mexican migrants and the logics of neoliberal multiculturalism
Origins of tobacco harm reduction in the UK: The ‘Product Modification Programme' (1972–1991)
Endorsements of reduced harm tobacco products share the same four premises that supported the product modification programme. Current tobacco harm reduction premises and policies supported by the British government and leading British public health organisations may reflect the historical influence of the tobacco industry
Revolution or redux? Assessing Iqos through a precursor product
IQOS appears to be a variant of Accord without consistent improvements in exposure to aerosol toxic compounds. In contrast to PM's past claims for Accord, PMI now claims in its MRTP application that IQOS reduces health risk. This shift in stance is likely not the result of any toxicological difference between Accord and IQOS, but rather a change in the social and regulatory landscape permitting these claims
Invisible smoke: Third-party endorsement and the resurrection of heat-not-burn tobacco products
Endorsement by high-impact medical journals and health authorities may be critical in helping heat-not-burn' products succeed where previous attempts have failed. Conflicts of interest influenced these endorsements in the past. Health leaders and academic journals should consider both conflicts of interest and the ethics of endorsing tobacco product substitution, as tobacco companies simultaneously work to promote cigarette smoking and undermine …
No prominent works on this page.
Origins of tobacco harm reduction in the UK: The ‘Product Modification Programme' (1972–1991)
Endorsements of reduced harm tobacco products share the same four premises that supported the product modification programme. Current tobacco harm reduction premises and policies supported by the British government and leading British public health organisations may reflect the historical influence of the tobacco industry
Revolution or redux? Assessing Iqos through a precursor product
IQOS appears to be a variant of Accord without consistent improvements in exposure to aerosol toxic compounds. In contrast to PM's past claims for Accord, PMI now claims in its MRTP application that IQOS reduces health risk. This shift in stance is likely not the result of any toxicological difference between Accord and IQOS, but rather a change in the social and regulatory landscape permitting these claims
Invisible smoke: Third-party endorsement and the resurrection of heat-not-burn tobacco products
Endorsement by high-impact medical journals and health authorities may be critical in helping heat-not-burn' products succeed where previous attempts have failed. Conflicts of interest influenced these endorsements in the past. Health leaders and academic journals should consider both conflicts of interest and the ethics of endorsing tobacco product substitution, as tobacco companies simultaneously work to promote cigarette smoking and undermine …
Financial Conflicts of Interest and Stance on Tobacco Harm Reduction: A Systematic Review
Background. Tobacco companies have actively promoted the substitution of cigarettes with purportedly safer tobacco products (e.g., smokeless tobacco, e-cigarettes) as tobacco harm reduction (THR). Given the tobacco, e-cigarette, and pharmaceutical industries’ substantial financial interests, we quantified industry influence on support for THR. Objectives. To analyze a comprehensive set of articles published in peer-reviewed journals assessing fun…
Docile, criminal, and upwardly mobile: Visual news framing of Mexican migrants and the logics of neoliberal multiculturalism
Law (4 works) · Law (4 works) · Political science (4 works) · Business (3 works) · Global Public Health Policies and Epidemiology (3 works) · Medicine (3 works) · Smoking Behavior and Cessation (3 works) · Tobacco industry (3 works) · Environmental health (2 works) · Product (mathematics (2 works)